Search

Author/Creator Malladi, R.

1. BRENTUXIMAB VEDOTIN FOR RELAPSED HODGKIN LYMPHOMA AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: a RETROSPECTIVE STUDY OF THE EBMT LYMPHOMA WORKING PARTY. (June 2017)

Authors:
Bazarbachi, A.; Boumendil, A.; Finel, H.; Mohty, M.; Castagna, L.; Blaise, D.; Peggs, K.; Afanasyev, B.; Diez‐Martin, J.; Corradini, P.; Socié, G.; Robinson, S.; Gutiérrez‐García, G.; Bonifazi, F.; Yakoub‐Agha, I.; Gülbas, Z.; Bloor, A.; Delage, J.; Esquirol, A.; Malladi, R.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
83
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Long‐term outcome of patients receiving haematopoietic allogeneic stem cell transplantation as first transplant for high‐risk Hodgkin lymphoma: a retrospective analysis from the Lymphoma Working Party‐EBMT. (8th November 2021)

Authors:
Gutiérrez‐García, G.; Martínez, C.; Boumendil, A.; Finel, H.; Malladi, R.; Afanasyev, B.; Tsoulkani, A.; Wilson, K. M. O.; Bloor, A.; Nikoloudis, M.; Richardson, D.; López‐Corral, L.; Castagna, L.; Cornelissen, J.; Giltat, A.; Collin, M.; Fanin, R.; Bonifazi, F.; Robinson, S.; Montoto, S.
Journal:
British journal of haematology
Issue:
Volume 196:Number 4(2022)
Page Start:
1018
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. NCRI PETREA TRIAL: A PHASE 3 EVALUATION OF PET‐GUIDED, RESPONSE‐ADAPTED THERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED, ADVANCED‐STAGE, HIGH‐TUMOUR‐BURDEN FOLLICULAR LYMPHOMA. (12th June 2019)

Authors:
Pettitt, A.R.; Barrington, S.; Kalakonda, N.; Khan, U.T.; Jackson, R.; Carruthers, S.; Oates, M.; Lin, K.; Ardeshna, K.; Eyre, T.; Fox, C.P.; Kennedy, B.; Linton, K.; Malladi, R.; Menne, T.; Okosun, J.; Paneesha, S.; Rule, S.; Johnston, A.; Trotman, J.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
67
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. PATIENT‐REPORTED QUALITY OF LIFE (QOL) FOLLOWING TISAGENLECLEUCEL (TISA‐CEL) INFUSION IN ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (R/R FL). (17th June 2021)

Authors:
Fowler, N. H.; Dickinson, M.; Martinez‐Lopez, J.; Kolstad, A.; Schuster, S. J.; Dreyling, M.; Ghosh, M.; Harigae, H.; Kersten, M. José; Bachy, E.; Popplewell, L.; Chavez, J. C.; Ho, P. J.; Butler, J.; Kato, K.; von Tresckow, B.; Ferreri, A. J. M.; Simón, J. A. P.; Patten, P. E. M.; Andreadis, C.
Journal:
Hematological oncology
Issue:
Volume 39(2021)Supplement 2
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. U.K. national audit of extracorporeal photopheresis in cutaneous T‐cell lymphoma. (12th January 2018)

Authors:
Sanyal, S.; Child, F.; Alfred, A.; Callaghan, T.; Alband, N.; Whittaker, S.; Cowan, R.; Parry, E.; Robinson, S.; Dunnill, M.G.S.; Wain, M.; Morris, S.; Malladi, R.; Tahir, S.; Howles, A.; Arumainathan, A.; Azurdia, R.; Grant‐Casey, J.; Matin, R. N.; Gilson, D.
Journal:
British journal of dermatology
Issue:
Volume 178:Number 2(2018)
Page Start:
569
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. U.K. national audit of extracorporeal photopheresis in cutaneous T‐cell lymphoma. (1st February 2018)

Authors:
Sanyal, S.; Child, F.; Alfred, A.; Callaghan, T.; Alband, N.; Whittaker, S.; Cowan, R.; Parry, E.; Robinson, S.; Dunnill, M.G.S.; Wain, M.; Morris, S.; Malladi, R.; Tahir, S.; Howles, A.; Arumainathan, A.; Azurdia, R.; Grant‐Casey, J.; Matin, R. N.; Gilson, D.
Journal:
British journal of dermatology
Issue:
Volume 178:Number 2(2018)
Page Start:
569
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗